Abraham Weizman
Overview
Explore the profile of Abraham Weizman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
590
Citations
7063
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
41.
Hen-Shoval D, Weller A, Weizman A, Shoval G
Int J Environ Res Public Health
. 2022 Jan;
19(1).
PMID: 35010782
Depression and anxiety disorders are two of the most common and growing mental health concerns in adolescents. Consequently, antidepressant medication (AD) use has increased widely during the last decades. Several...
42.
Bareli T, Ahdoot H, Ben Moshe H, Barnea R, Warhaftig G, Gispan I, et al.
Front Behav Neurosci
. 2022 Jan;
15:788708.
PMID: 35002647
Substance use disorders (SUDs) are associated with depression and anxiety, with the latter being one of the major factors in substance-seeking and relapse. Due to dose-dependent sedative side effects there...
43.
Gabay M, Weizman A, Zeineh N, Kahana M, Obeid F, Allon N, et al.
Cell Mol Neurobiol
. 2021 Dec;
42(4):1265.
PMID: 34932175
No abstract available.
44.
De Leon J, Schoretsanitis G, Smith R, Molden E, Solismaa A, Seppala N, et al.
Pharmacopsychiatry
. 2021 Dec;
55(2):73-86.
PMID: 34911124
This international guideline proposes improving clozapine package inserts worldwide by using ancestry-based dosing and titration. Adverse drug reaction (ADR) databases suggest that clozapine is the third most toxic drug in...
45.
Ahdoot-Levi H, Croitoru O, Bareli T, Sudai E, Peer-Nissan H, Jacob A, et al.
Front Neurosci
. 2021 Dec;
15:773197.
PMID: 34899172
Cocaine addiction is an acquired behavioral state developed in vulnerable individuals after cocaine exposure. It is characterized by compulsive drug-seeking and high vulnerability to relapse even after prolonged abstinence, associated...
46.
Taler M, Mekori-Domachevsky E, Vergaelen E, Claes S, Serur Y, Dar S, et al.
World J Biol Psychiatry
. 2021 Dec;
23(6):475-482.
PMID: 34854358
Objective: To evaluate the relationship between psychosis and BBB permeability in this population. Methods: We examined two biomarkers for BBB permeability, s100β and neuron-specific enolase (NSE), in 22q11.2DS individuals with/without...
47.
Monga S, Denora N, Laquintana V, Yashaev R, Weizman A, Gavish M
Biology (Basel)
. 2021 Nov;
10(11).
PMID: 34827176
Parkinson's disease (PD) is a progressive neurodegenerative disorder which is characterized by the degeneration of dopaminergic neurons in substantia nigra (SN). Oxidative stress or reactive oxygen species (ROS) generation was...
48.
Krivoy A, Shrot S, Avrahami M, Fischel T, Weizman A, Mardor Y, et al.
Isr Med Assoc J
. 2021 Oct;
23(10):625-630.
PMID: 34672443
Background: Only a small proportion of schizophrenia patients present with catatonic symptoms. Imaging studies suggest that brain motor circuits are involved in the underlying pathology of catatonia. However, data about...
49.
Monga S, Denora N, Laquintana V, Franco M, Marek I, Singh S, et al.
Brain Behav Immun Health
. 2021 Sep;
5:100083.
PMID: 34589858
We have shown previously, that the 18 kDa translocator protein (TSPO) synthetic ligands quinazoline derivatives (2-Cl-MGV-1 and MGV-1) can inhibit activation of in BV-2 microglial cells. In the present study...
50.
Lauden A, Geishin A, Merzon E, Korobeinikov A, Green I, Golan-Cohen A, et al.
Brain Behav Immun Health
. 2021 Sep;
16:100313.
PMID: 34589804
Only 30% of patients with major depressive disorder (MDD) reach full recovery or remission. Treatment-resistant depression (TRD) is MDD that does not respond to adequate treatment attempts with at least...